Carl N. Kraus - Aug 9, 2025 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Chief Medical Officer
Signature
/s/ Lori Braender, as Attorney-In-Fact
Stock symbol
AQST
Transactions as of
Aug 9, 2025
Transactions value $
-$42,194
Form type
4
Date filed
8/12/2025, 10:11 AM
Previous filing
Mar 11, 2025
Next filing
Oct 17, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kraus Carl N Chief Medical Officer C/O AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE, WARREN /s/ Lori Braender, as Attorney-In-Fact 2025-08-12 0001946475

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AQST Common Stock Tax liability -$42.2K -10.8K -3.45% $3.90 303K Aug 9, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.